RedHill Biopharma (RDHL) Short Interest Ratio & Short Volume → Central Banks Preparing for US Dollar Collapse? (From Behind the Markets) (Ad) Free RDHL Stock Alerts $0.53 +0.01 (+1.94%) (As of 03/28/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media RedHill Biopharma Short Interest DataCurrent Short Volume1,060,000 sharesPrevious Short Volume376,200 sharesChange Vs. Previous Month+181.77%Dollar Volume Sold Short$558,408.00Short Interest Ratio / Days to Cover0.8Last Record DateMarch 15, 2024Outstanding Shares29,700,000 sharesFloat Size29,550,000 sharesShort Percent of Float3.59%Today's Trading Volume500,785 sharesAverage Trading Volume852,219 sharesToday's Volume Vs. Average59% Short Selling RedHill Biopharma ? Sign up to receive the latest short interest report for RedHill Biopharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatRDHL Short Interest Over TimeRDHL Days to Cover Over TimeRDHL Percentage of Float Shorted Over Time Ad Gold Safe ExchangeTrump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… RedHill Biopharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/20241,060,000 shares $558,408.00 +181.8%3.6%0.8 $0.53 2/29/2024376,200 shares $231,363.00 -38.9%1.3%0.2 $0.62 2/15/2024615,700 shares $334,756.09 -44.5%2.1%0.1 $0.54 1/31/20241,110,000 shares $643,800.00 +263.1%3.8%0.1 $0.58 1/15/2024305,700 shares $324,042.00 -57.5%1.6%0 $1.06 12/31/2023720,000 shares $1.05 million +149.3%3.7%0.1 $1.46 Get the Latest News and Ratings for RDHL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for RedHill Biopharma and its competitors with MarketBeat's FREE daily newsletter. 12/15/2023288,800 shares $329,232.00 -93.9%1.5%0 $1.14 11/30/20234,740,000 shares $9.48 million +16,188.7%24.2%0.5 $2.00 11/15/202329,100 shares $9,748.50 -90.1%0.3%0 $0.34 10/31/2023293,600 shares $129,184.00 +153.1%2.7%0.2 $0.44 10/15/2023116,000 shares $37,120.00 +590.5%1.1%0.1 $0.32 9/30/202316,800 shares $8,568.00 +200.0%0.3%0 $0.51 9/15/20235,600 shares $4,760.00 -27.3%0.1%0 $0.85 8/31/20237,700 shares $6,768.30 +102.6%0.1%0 $0.88 8/15/20233,800 shares $3,156.66 -85.7%0.1%0 $0.83 7/31/202326,600 shares $34,048.00 -77.7%0.5%0.1 $1.28 7/15/2023119,400 shares $213,726.00 +594.2%4.1%0.6 $1.79 6/30/202317,200 shares $20,640.00 -39.0%0.6%0.1 $1.20 6/15/202328,200 shares $54,990.00 -64.5%1.0%0.3 $1.95 5/31/202379,400 shares $184,208.00 -31.9%2.7%0.8 $2.32 5/15/2023116,600 shares $267,014.00 -31.7%4.0%1.2 $2.29 4/30/2023170,700 shares $414,801.00 +9.4%6.4%1.6 $2.43 4/15/2023156,100 shares $501,081.00 +25.6%5.8%1 $3.21 3/31/2023124,300 shares $508,387.00 -11.7%5.1%0.8 $4.09 3/15/2023140,800 shares $1.01 million -97.8%N/A0.9 $7.16 2/28/20236,410,000 shares $1.45 million -3.0%N/A1.1 $0.23 2/15/20236,610,000 shares $1.41 million -18.5%N/A1.1 $0.21 1/31/20238,110,000 shares $1.77 million +279.0%N/A1.4 $0.22 1/15/20232,140,000 shares $422,650.00 +22.3%N/A0.7 $0.20 12/30/20221,750,000 shares $245,525.00 +32.6%N/A0.4 $0.14 12/15/20221,320,000 shares $252,120.00 -47.6%N/A0.4 $0.19 11/30/20222,520,000 shares $907,200.00 +22.3%N/A0.8 $0.36 11/15/20222,060,000 shares $1.13 million -14.9%N/A0.7 $0.55 10/31/20222,420,000 shares $1.68 million -8.0%N/A0.9 $0.70 10/15/20222,630,000 shares $1.36 million -1.1%N/A0.9 $0.52 9/30/20222,660,000 shares $1.34 million +60.2%N/A1.8 $0.50 9/15/20221,660,000 shares $1.32 million No ChangeN/A0.7 $0.80 8/31/20221,660,000 shares $1.49 million +4.4%N/A0.5 $0.90 8/15/20221,590,000 shares $1.65 million -7.6%N/A0.5 $1.04 7/31/20221,720,000 shares $1.50 million -16.9%N/A0.6 $0.87Trump’s “Tax Free” Retirement Strategy (Ad)Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… RDHL Short Interest - Frequently Asked Questions What is RedHill Biopharma's current short interest? Short interest is the volume of RedHill Biopharma shares that have been sold short but have not yet been covered or closed out. As of March 15th, investors have sold 1,060,000 shares of RDHL short. 3.59% of RedHill Biopharma's shares are currently sold short. Learn More on RedHill Biopharma's current short interest. What is a good short interest ratio for RedHill Biopharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RDHL shares currently have a short interest ratio of 1.0. Learn More on RedHill Biopharma's short interest ratio. Which institutional investors are shorting RedHill Biopharma? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of RedHill Biopharma: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for RedHill Biopharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.59% of RedHill Biopharma's floating shares are currently sold short. Is RedHill Biopharma's short interest increasing or decreasing? RedHill Biopharma saw a increase in short interest during the month of March. As of March 15th, there was short interest totaling 1,060,000 shares, an increase of 181.8% from the previous total of 376,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is RedHill Biopharma's float size? RedHill Biopharma currently has issued a total of 29,700,000 shares. Some of RedHill Biopharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. RedHill Biopharma currently has a public float of 29,550,000 shares. How does RedHill Biopharma's short interest compare to its competitors? 3.59% of RedHill Biopharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to RedHill Biopharma: RenovoRx, Inc. (0.18%), VBI Vaccines Inc. (1.36%), ABVC BioPharma, Inc. (1.29%), Cocrystal Pharma, Inc. (0.05%), TFF Pharmaceuticals, Inc. (1.96%), Edesa Biotech, Inc. (0.75%), Benitec Biopharma Inc. (0.22%), Purple Biotech Ltd. (0.88%), NuCana plc (5.74%), Molecular Templates, Inc. (0.62%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Cummins Inc. ($8.93 billion), Canadian Natural Resources Limited ($7.79 billion), Super Micro Computer, Inc. ($4.31 billion), T-Mobile US, Inc. ($4.00 billion), General Motors ($3.36 billion), Occidental Petroleum Co. ($3.10 billion), Charter Communications, Inc. ($2.92 billion), Coinbase Global, Inc. ($2.74 billion), Tractor Supply ($2.72 billion), and Moderna, Inc. ($2.31 billion). View all of the most shorted stocks. What does it mean to sell short RedHill Biopharma stock? Short selling RDHL is an investing strategy that aims to generate trading profit from RedHill Biopharma as its price is falling. RDHL shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against RedHill Biopharma? A short squeeze for RedHill Biopharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RDHL, which in turn drives the price of the stock up even further. How often is RedHill Biopharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RDHL, twice per month. The most recent reporting period available is March, 15 2024. More Short Interest Resources from MarketBeat Related Companies: RenovoRx Short Interest Data VBI Vaccines Short Interest Data ABVC BioPharma Short Interest Data Cocrystal Pharma Short Interest Data TFF Pharmaceuticals Short Interest Data Edesa Biotech Short Interest Data Benitec Biopharma Short Interest Data Purple Biotech Short Interest Data NuCana Short Interest Data Molecular Templates Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RDHL) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders Alliance“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyFed launches fourth dollar overhaulStansberry Research